ReviewTranslational oncology2026
Programmed death 1 antibody drug conjugates (PD 1 ADCs): Innovations in overcoming resistance and enhancing immune mediated antitumor activity.
Zilong TianPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.